Visanu Wanchai

Instructor

UAMS

Also affiliated: Oak Ridge National Laboratory (2015–2017); Molecular Microbiology and Genomics Consultants (Germany) (2017); Institute for Musculoskeletal Health (2025); Winthrop Rockefeller Foundation (2022–2024); Institute of Informatics of the Slovak Academy of Sciences (2025)

Faculty Researcher

Biomedical Informatics, College of Medicine

15 h-index 50 pubs 1,014 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group UAMS TRI Profile

OverviewAI-generated summary

Visanu Wanchai's research focuses on the application of bioinformatics and genomics to understand biological systems. His work includes analyzing bacterial genomes to determine phylogroups, as demonstrated in his publication on Escherichia coli. Wanchai has also investigated methods for identifying extrachromosomal circular DNA using long-read sequencing, contributing to the advancement of molecular biology techniques. His research extends to viral genomics, with studies on the genetic repertoire of SARS-CoV-2 during the COVID-19 pandemic and comparisons of Monkeypox virus genomes. Additionally, Wanchai has explored the genetic underpinnings of diseases such as multiple myeloma, examining immune microenvironment alterations and investigating therapeutic approaches like bispecific CAR-T cells. He also contributes to the study of animal models, refining the identification of cell types associated with bone structures in mice.

Metrics

h-index: 15
Publications: 50
Citations: 1,014

Selected Publications

Protocol for the enrichment of endosteal and periosteal mesenchymal cells from murine bone for single-cell transcriptome analysis (2026)

STAR Protocols DOI OpenAlex
A transcriptomic-driven segmentation and cell simulation framework for high-resolution spatial transcriptomics and cell-cell communication (2026)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
visanuwan/TENGU: V0.1.0 (2026)

Zenodo (CERN European Organization for Nuclear Research) DOI OpenAlex
visanuwan/TENGU: V0.1.0 (2026)

Open MIND DOI OpenAlex
Abstract 2326: Differentiating epigenetic marks and DNA adducts at the KRAS codon 12 mutation hotspot using ONT/ELIGOS sequencing (2026)

Cancer Research DOI OpenAlex
An enhancement of extrachromosomal circular DNA enrichment and amplification to address the extremely low overlap between replicates (2026)

Journal of Biological Chemistry DOI OpenAlex
Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength (2025)

JCI Insight 11 citations DOI OpenAlex
An Enhancement of Extrachromosomal Circular DNA Enrichment and Amplification to Address the Extremely Low Overlap Between Replicates (2025)

bioRxiv (Cold Spring Harbor Laboratory) DOI OpenAlex
Single Nuclei Multiomic Profiling of Transcriptional and Chromatin Accessibility of Tumor Cells Underlines Extensive Cis-Regulatory Interaction during Multiple Myeloma Progression (2024)

Blood DOI OpenAlex
Multi-Omics Reveal Immune Microenvironment Alterations in Multiple Myeloma and Its Precursor Stages (2024)

Blood 1 citation DOI OpenAlex
Multi-omics reveal immune microenvironment alterations in multiple myeloma and its precursor stages (2024)

Blood Cancer Journal 35 citations DOI OpenAlex
DNA structural features and variability of complete MHC locus sequences (2024)

Frontiers in Bioinformatics 7 citations DOI OpenAlex
A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation (2024)

Cancers 4 citations DOI OpenAlex
Refining the identity of mesenchymal cell types associated with murine periosteal and endosteal bone (2024)

Journal of Biological Chemistry 32 citations DOI OpenAlex
Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth (2024)

Nature Communications 46 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

As listed on this researcher's institutional profile.

Center for Musculoskeletal Disease Research (CMDR) NIH/Nat. Inst. of General Medical Sciences Principal Investigator
Project 1 – Prevention of MGUS progression to MM by modulating the bone marrow microenvironment NIH/Nat. Cancer Institute via Baylor College of Medicine Principal Investigator